Review




Structured Review

Pfizer Inc bivalent pfizer bnt vaccine
Bivalent Pfizer Bnt Vaccine, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bivalent+pfizer+bnt+vaccine/bivalent+bnt+pfizer+vaccine/pmc12390948__mmc5-912-44-45
Average 86 stars, based on 1 article reviews
bivalent pfizer bnt vaccine - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Immunopeptidomics:

Article Title: Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial
Article Snippet: .. Sample size calculation for primary immunogenicity objective The sample size calculation is based on these hypothesis testings of immunobridging analysis determined by the results of pseudovirus neutralizing antibody titer (pSVNT-50) against wildtype virus at 4 weeks after the booster dose of COMVIGEN vaccine or BIVALENT Pfizer/BNT vaccine, including: 1) Non-inferiority is declared if the lower bound of the 95% two-sided confidence interval for GMR greater than 0.67. .. The sample size was calculated based on the assumptions that point estimate of the GMR at 0.90, non-inferiority margin of GMR at 0.67, standard deviation in natural log scale at 0.89 (according to phase 2 study comparing between ChulaCov and Pfizer vaccines).

Article Title: Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial
Article Snippet: .. 8.1 Sample Size Calculation Sample size calculation for primary immunogenicity objective: Version 1.0; 17SEP2024 CONFIDENTIAL Page 62 of 231 The sample size calculation is based on these hypothesis testings of immunobridging analysis determined by the results of pseudovirus neutralizing antibody titer (pSVNT-50) against wild-type virus at 4 weeks after the booster dose of COMVIGEN vaccine or BIVALENT Pfizer/BNT vaccine, including: 1) Non-inferiority is declared if the lower bound of the 95% two-sided confidence interval for GMR greater than 0.67. .. The sample size was calculated based on the assumptions that point estimate of the GMR at 0.90, non-inferiority margin of GMR at 0.67, standard deviation in natural log scale at 0.89 (according to phase 2 study comparing between ChulaCov and Pfizer vaccines).

Virus:

Article Title: Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial
Article Snippet: .. Sample size calculation for primary immunogenicity objective The sample size calculation is based on these hypothesis testings of immunobridging analysis determined by the results of pseudovirus neutralizing antibody titer (pSVNT-50) against wildtype virus at 4 weeks after the booster dose of COMVIGEN vaccine or BIVALENT Pfizer/BNT vaccine, including: 1) Non-inferiority is declared if the lower bound of the 95% two-sided confidence interval for GMR greater than 0.67. .. The sample size was calculated based on the assumptions that point estimate of the GMR at 0.90, non-inferiority margin of GMR at 0.67, standard deviation in natural log scale at 0.89 (according to phase 2 study comparing between ChulaCov and Pfizer vaccines).

Article Title: Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial
Article Snippet: .. 8.1 Sample Size Calculation Sample size calculation for primary immunogenicity objective: Version 1.0; 17SEP2024 CONFIDENTIAL Page 62 of 231 The sample size calculation is based on these hypothesis testings of immunobridging analysis determined by the results of pseudovirus neutralizing antibody titer (pSVNT-50) against wild-type virus at 4 weeks after the booster dose of COMVIGEN vaccine or BIVALENT Pfizer/BNT vaccine, including: 1) Non-inferiority is declared if the lower bound of the 95% two-sided confidence interval for GMR greater than 0.67. .. The sample size was calculated based on the assumptions that point estimate of the GMR at 0.90, non-inferiority margin of GMR at 0.67, standard deviation in natural log scale at 0.89 (according to phase 2 study comparing between ChulaCov and Pfizer vaccines).



Similar Products

86
Pfizer Inc bivalent pfizer bnt vaccine
Bivalent Pfizer Bnt Vaccine, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bivalent+pfizer+bnt+vaccine/bivalent+bnt+pfizer+vaccine/pmc12390948__mmc5-912-44-45
Average 86 stars, based on 1 article reviews
bivalent pfizer bnt vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Pfizer Inc covid-19 vaccine omicron ba.4/ba.5-adapted bivalent vaccine (pfizer/bnt)
Covid 19 Vaccine Omicron Ba.4/Ba.5 Adapted Bivalent Vaccine (Pfizer/Bnt), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bivalent+pfizer+bnt+vaccine/omicron+ba+1+containing+pfizer+vaccines/pm37897026-141-10-14
Average 90 stars, based on 1 article reviews
covid-19 vaccine omicron ba.4/ba.5-adapted bivalent vaccine (pfizer/bnt) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results